Phenocell is a Partner Research Organization for the pharmaceutical and dermo-cosmetic industry, specialized in bioassays based on iPSC-derived cellular models for research and drug discovery.
We are here to improve your R&D programs with highly relevant in vitro tools available in unlimited amounts and with fully qualified characteristics, including control of genetic background.
Using the Nobel Prize winning technology of cell reprogramming, we create foot-print free, xeno-free, human iPSC. Selected iPSC are differentiated into somatic cells and associated to tailor-made phenotypic assays to repurpose existing drugs and discover or validate tomorrow's medicines.
From the magazine "Pharmaceutiques" (available in French) | Phenocell is mentioned along other French flagships such as Sanofi as the forefront of innovative biotherapies.
Phenocell was mentionned in the "Planete Agro" magazine as part of a day of visits in the Biotech and Perfume flagship industries of the Grasse region in the south of France. (Article available in French)